Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Hydroquinone measurement |
Component |
True |
Hydroquinone (substance) |
Inferred relationship |
Some |
1 |
Hydroquinone 20 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydroquinone (substance) |
Inferred relationship |
Some |
|
Hydroquinone 4% gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydroquinone (substance) |
Inferred relationship |
Some |
|
Product containing precisely hydroquinone 30 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydroquinone (substance) |
Inferred relationship |
Some |
|
Hydroquinone 30mg solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydroquinone (substance) |
Inferred relationship |
Some |
|
Hydroquinone 40mg cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydroquinone (substance) |
Inferred relationship |
Some |
|
Hydroquinone 40mg/gram cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydroquinone (substance) |
Inferred relationship |
Some |
|
Product containing precisely hydroquinone 40 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydroquinone (substance) |
Inferred relationship |
Some |
|
Product containing hydroquinone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydroquinone (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely mequinol 20 milligram/1 milliliter and tretinoin 100 microgram/1 milliliter conventional release cutaneous solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydroquinone (substance) |
Inferred relationship |
Some |
|
Product containing mequinol and tretinoin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydroquinone (substance) |
Inferred relationship |
Some |
|
Product containing mequinol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydroquinone (substance) |
Inferred relationship |
Some |
|
Product containing fluocinolone acetonide and hydroquinone and tretinoin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydroquinone (substance) |
Inferred relationship |
Some |
|
Fluocinolone acetonide 100 microgram/mL and hydroquinone 40 mg/mL and tretinoin 500 microgram/mL cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydroquinone (substance) |
Inferred relationship |
Some |
|
Hydroquinone + sunscreen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydroquinone (substance) |
Inferred relationship |
Some |
|
Mequinol (substance) |
Is a |
False |
Hydroquinone (substance) |
Inferred relationship |
Some |
|
Ochronosis caused by hydroquinone (disorder) |
Causative agent (attribute) |
False |
Hydroquinone (substance) |
Inferred relationship |
Some |
3 |
Product containing precisely hydroquinone 40 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydroquinone (substance) |
Inferred relationship |
Some |
|
Hydroquinone 20 mg/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydroquinone (substance) |
Inferred relationship |
Some |
1 |
Hydroquinone 20 mg/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydroquinone (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely hydroquinone 40 milligram/1 gram conventional release cutaneous cream (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydroquinone (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely hydroquinone 40 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydroquinone (substance) |
Inferred relationship |
Some |
1 |
Product containing fluocinolone and hydroquinone and tretinoin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydroquinone (substance) |
Inferred relationship |
Some |
2 |
Hydroquinone-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydroquinone (substance) |
Inferred relationship |
Some |
1 |
Fluocinolone and hydroquinone and tretinoin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydroquinone (substance) |
Inferred relationship |
Some |
2 |
Product containing only hydroquinone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydroquinone (substance) |
Inferred relationship |
Some |
1 |
Hydroquinone only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydroquinone (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely hydroquinone 30 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydroquinone (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely hydroquinone 30 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydroquinone (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely hydroquinone 40 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydroquinone (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely hydroquinone 40 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydroquinone (substance) |
Inferred relationship |
Some |
1 |
Fluocinolone acetonide 100 microgram/mL and hydroquinone 40 mg/mL and tretinoin 500 microgram/mL cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydroquinone (substance) |
Inferred relationship |
Some |
2 |
Fluocinolone acetonide 100 microgram/mL and hydroquinone 40 mg/mL and tretinoin 500 microgram/mL cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydroquinone (substance) |
Inferred relationship |
Some |
2 |
Fluocinolone and hydroquinone and tretinoin only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydroquinone (substance) |
Inferred relationship |
Some |
2 |
Fluocinolone- and hydroquinone- and tretinoin-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydroquinone (substance) |
Inferred relationship |
Some |
2 |
Ochronosis caused by hydroquinone (disorder) |
Causative agent (attribute) |
True |
Hydroquinone (substance) |
Inferred relationship |
Some |
1 |